Arkolith/Insider Trading/ADXN/Form 4

Teyssedou Lenaic Nathanael

PRINCIPAL ACCOUNTING OFFICERAddex Therapeutics Ltd. (ADXN) · full profile →Form 4 · filed Sep 4, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
16
0 non-derivative · 16 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 2, 2026Disposed to issuer(D)38K—$0565K
Sep 2, 2026Grant(A)38K—$0603K
Sep 2, 2026Disposed to issuer(D)60K—$0543K
Sep 2, 2026Grant(A)60K—$0603K
Sep 2, 2026Disposed to issuer(D)10K—$0593K
Sep 2, 2026Grant(A)10K—$0603K
Sep 2, 2026Disposed to issuer(D)30K—$0573K
Sep 2, 2026Grant(A)30K—$0603K
Sep 2, 2026Disposed to issuer(D)66K—$0537K
Sep 2, 2026Grant(A)66K—$0603K
Sep 2, 2026Disposed to issuer(D)91K—$0512K
Sep 2, 2026Grant(A)91K—$0603K
Sep 2, 2026Disposed to issuer(D)209K—$0394K
Sep 2, 2026Grant(A)209K—$0603K
Sep 2, 2026Disposed to issuer(D)100K—$0502K
Sep 2, 2026Grant(A)100K—$0603K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-105509) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Addex Therapeutics Ltd.

Build

Ask your agent about ADXN insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001104659-26-105509"
Ask your agent
Use Arkolith to summarize insider buying and selling at Addex Therapeutics Ltd.
over the last 90 days and cite the filings.